Summit Therapeutics Starts Phase III HARMONi-10 Study of Ivonescimab
Summit initiated HARMONi-10, a global Phase III trial comparing ivonescimab with AstraZeneca's durva…
Summit initiated HARMONi-10, a global Phase III trial comparing ivonescimab with AstraZeneca's durva…